Nolvadex and Zometa drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Nolvadex (tamoxifen citrate) and Zometa (zoledronic acid). Common drug interactions include bone disorder among females and bone lesion among males.
The phase IV clinical study analyzes what interactions people have when they take Nolvadex and Zometa. It is created by eHealthMe based on reports of 288 people who take the same drugs from the FDA, and is updated regularly.
What is Nolvadex?
Nolvadex has active ingredients of tamoxifen citrate. It is often used in breast cancer. eHealthMe is studying from 5,506 Nolvadex users. Check the latest studies of Nolvadex.
What is Zometa?
Zometa has active ingredients of zoledronic acid. It is often used in multiple myeloma. eHealthMe is studying from 71,434 Zometa users. Check the latest studies of Zometa.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
288 people who take Nolvadex and Zometa together, and have interactions are studied.
What are the common drug interactions of Nolvadex and Zometa, by gender? *
What are the common drug interactions of Nolvadex and Zometa, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Nolvadex and Zometa?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Nolvadex and Zometa:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Nolvadex:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Zometa:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Nolvadex and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Zometa and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- K?rm?z?bekmez H, Yesiltepe Mutlu RG, Dursun F, ??güven ?P, "Tamoxifen-associated hirsutism: an unusual side effect in a 5-year-old girl with McCune-Albright syndrome", Journal of Pediatric Endocrinology and Metabolism, 2015 Sep .
- K?rm?z?bekmez H, Yesiltepe Mutlu RG, Dursun F, ??güven ?P, "Tamoxifen-associated hirsutism: an unusual side effect in a 5-year-old girl with McCune-Albright syndrome", Journal of Pediatric Endocrinology and Metabolism, 2015 Sep .
How the study uses the data?
The study uses data from the FDA. It is based on tamoxifen citrate and zoledronic acid (the active ingredients of Nolvadex and Zometa, respectively), and Nolvadex and Zometa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Bronchitis and drugs of ingredients of memantine hydrochloride - 4 seconds ago
- Stress And Anxiety in Methylin, how severe and when it was recovered? - 5 seconds ago
- Epidermal Necrolysis and drugs of ingredients of heparin sodium - 10 seconds ago
- Tagamet and Losartan drug interactions for men aged 60+ - 17 seconds ago
- Could Spironolactone cause Renal Injury? - 20 seconds ago
- Could Prednisone cause Injection Site Discoloration? - 21 seconds ago
- Drug interactions of Zestril and Caffeine Citrate - 24 seconds ago
- Monopril-Hct vs. Dynacirc Cr, side effect and effectiveness comparison - 49 seconds ago
- Drug interactions of Tracleer and Ibu - 50 seconds ago
- Renal Neoplasm and drugs of ingredients of insulin aspart recombinant - 51 seconds ago